Breast Cancer and Its Relationship with the Microbiota
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
The microorganisms that live symbiotically in human beings are increasingly recognized as important players in health and disease. The largest collection of these microorganisms is found in the gastrointestinal tract. Microbial composition reflects both genetic and lifestyle variables of the host. This microbiota is in a dynamic balance with the host, exerting local and distant effects. Microbial perturbation (dysbiosis) could contribute to the risk of developing health problems. Various bacterial genes capable of producing estrogen-metabolizing enzymes have been identified. Accordingly, gut microbiota is capable of modulating estrogen serum levels. Conversely, estrogen-like compounds may promote the proliferation of certain species of bacteria. Therefore, a crosstalk between microbiota and both endogenous hormones and estrogen-like compounds might synergize to provide protection from disease but also to increase the risk of developing hormone-related diseases. Recent research suggests that the microbiota of women with breast cancer differs from that of healthy women, indicating that certain bacteria may be associated with cancer development and with different responses to therapy. In this review, we discuss recent knowledge about the microbiome and breast cancer, identifying specific characteristics of the human microbiome that may serve to develop novel approaches for risk assessment, prevention and treatment for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, this sudden rise in estrogen increases the risk of developing breast cancer [436].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [436]
Experimental — accuracy not yet measuredIn the citing paper
“Accordingly, this augmented intake of estrogen hormones is linked with an increased risk of developing breast cancer, supporting the finding that the gut microbiota composition of women with breast cancer differs from that from healthy controls, and suggesting that several gut bacteria, which could be over-expressed during dysbiosis, may be linked with breast cancer development [83].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Subbaramaiah, K., Morris, P. G., Zhou, X. K., Morrow, M., Du, B., Giri, D., Kopelovich, L., Hudis, C. A., & Dannenberg, A. J. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0241 · Cited by 244
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 2×
“The gut microbiota has been also related to the development of adiposity and obesity [55], and it is known that overweight and obese women have a higher risk of BC compared to healthy weight women, especially during the postmenopausal period [56].”
Background
Cited by
Gut Bacteroides species in health and disease
Zafar, H., & Saier, M. H. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1848158 · Cited by 1,233
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
Role of microbiota-derived short-chain fatty acids in cancer development and prevention
Mirzaei, R., Afaghi, A., Babakhani, S., Sohrabi, M. R., Hosseini-Fard, S. R., Babolhavaeji, K., Khani Ali Akbari, S., Yousefimashouf, R., & Karampoor, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111619 · Cited by 394
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
The Microbiome–Estrogen Connection and Breast Cancer Risk
Parida, S., & Sharma, D. (2019) · Cells · doi:10.3390/cells8121642 · Cited by 241
Role of lung and gut microbiota on lung cancer pathogenesis
Zhao, Y., Liu, Y., Li, S., Peng, Z., Liu, X., Chen, J., & Zheng, X. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03644-0 · Cited by 212
Yin, C., Noratto, G. D., Fan, X., Chen, Z., Yao, F., Shi, D., & Gao, H. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116942 · Cited by 210
Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment
Laborda-Illanes, A., Sanchez-Alcoholado, L., Dominguez-Recio, M. E., Jimenez-Rodriguez, B., Lavado, R., Comino-Méndez, I., Alba, E., & Queipo-Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12092465 · Cited by 206
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
Thomas, R., Al-Khadairi, G., & Decock, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.600573 · Cited by 202
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
Terrisse, S., Derosa, L., Iebba, V., Ghiringhelli, F., Vaz-Luis, I., Kroemer, G., Fidelle, M., Christodoulidis, S., Segata, N., Thomas, A. M., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00784-1 · Cited by 172
“of the gut microbiome on BC risk or prognosis [33].”
BackgroundMicrobiota-Derived Metabolites in Tumor Progression and Metastasis
Rossi, T., Vergara, D., Fanini, F., Maffia, M., Bravaccini, S., & Pirini, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165786 · Cited by 161
Ashique, S., De Rubis, G., Sirohi, E., Mishra, N., Rihan, M., Garg, A., Reyes, R.-J., Manandhar, B., Bhatt, S., Jha, N. K., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110231 · Cited by 161
Microbiome and Breast Cancer: New Role for an Ancient Population
Eslami-S, Z., Majidzadeh-A, K., Halvaei, S., Babapirali, F., & Esmaeili, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00120 · Cited by 153
Sári, Z., Mikó, E., Kovàcs, T., Jankó, L., Csonka, T., Lente, G., Sebő, É., Tóth, J., Tóth, D., Árkosy, P., et al. (2020) · Cancers · doi:10.3390/cancers12092411 · Cited by 169
Plaza-Díaz, J., Solís-Urra, P., Rodríguez-Rodríguez, F., Olivares-Arancibia, J., Navarro-Oliveros, M., Abadía-Molina, F., & Álvarez-Mercado, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218351 · Cited by 145
Self-citationPlaza‐Díaz, J., Álvarez‐Mercado, A. I., Ruiz‐Marín, C. M., Reina-Pérez, I., Pérez-Alonso, A. J., Sánchez-Andujar, M. B., Torné, P., Gallart‐Aragón, T., Sánchez‐Barrón, M. T., Lartategui, S. D. R., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5660-y · Cited by 156
Self-citationAraújo-Rodrigues, H., Sousa, A. S., Relvas, J. B., Tavaria, F. K., & Pintado, M. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.121978 · Cited by 157
The Microbiome as a Component of the Tumor Microenvironment
Kovàcs, T., Mikó, E., Ujlaki, G., Sári, Z., & Bai, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_10 · Cited by 140
Estrogens and the risk of breast cancer: A narrative review of literature
Al‐Shami, K., Awadi, S., Khamees, A., Alsheikh, A. M., Al-Sharif, S., Bereshy, R., Al-Eitan, S. F., Banikhaled, S. H., Al-Qudimat, A. R., Al‐Zoubi, R. M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20224 · Cited by 180
Breast and gut microbiome in health and cancer
Zhang, J., Xia, Y., & Sun, J. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2020.08.002 · Cited by 125
Prognostic correlations with the microbiome of breast cancer subtypes
Banerjee, S., Wei, Z., Tian, T., Bose, D., Shih, N. N. C., Feldman, M. D., Khoury, T., De Michele, A., & Robertson, E. S. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04092-x · Cited by 117
Oncogenes and tumor suppressor genes: functions and roles in cancers
Dakal, T. C., Dhabhai, B., Pant, A., Moar, K., Chaudhary, K., Yadav, V., Ranga, V., Sharma, N. K., Kumar, A., Maurya, P. K., et al. (2024) · MedComm · doi:10.1002/mco2.582 · Cited by 172
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study
Wu, A. H., Tseng, C., Vigen, C., Yu, Y., Cozen, W., Garcia, A. A., & Spicer, D. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05702-6 · Cited by 111
The association between gut butyrate‐producing bacteria and non‐small‐cell lung cancer
Gui, Q., Li, H., Wang, A., Zhao, X., Tan, Z., Chen, L., Xu, K., & Xiao, C. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23318 · Cited by 112
Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms
Mei, S., Ma, H., & Chen, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.111997 · Cited by 98
Bobin-Dubigeon, C., Luu, H. T., Leuillet, S., Lavergne, S. N., Carton, T., Le Vacon, F., Michel, C., Nazih, H., & Bard, J.-M. (2021) · Nutrients · doi:10.3390/nu13082705 · Cited by 90
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Nandi, D., Parida, S., & Sharma, D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221452 · Cited by 109
Recentrifuge: Robust comparative analysis and contamination removal for metagenomics
Martí, J. M. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006967 · Cited by 108
The Many Faces of Obesity and Its Influence on Breast Cancer Risk
Agurs‐Collins, T., Ross, S. A., & Dunn, B. K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00765 · Cited by 108
Chen, L., Zhou, X., Wang, Y., Wang, D., Ke, Y., & Zeng, X. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100096 · Cited by 101
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
Lorenzo, A. D., Bolli, E., Tarone, L., Cavallo, F., & Conti, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249418 · Cited by 105
Doocey, C. M., Finn, K., Murphy, C. P., & Guinane, C. M. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02465-6 · Cited by 110
Ruo, S. W., Alkayyali, T., Win, M., Tara, A., Joseph, C., Kannan, A., Srivastava, K., Ochuba, O., Sandhu, J. K., Went, T. R., et al. (2021) · Cureus · doi:10.7759/cureus.17472 · Cited by 87
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Álvarez‐Mercado, A. I., Cano, A. D. V., Fernández, M. F., & Fontana, L. (2023) · Cancers · doi:10.3390/cancers15020443 · Cited by 105
Self-citationÁlvarez‐Mercado, A. I., & Plaza‐Díaz, J. (2022) · Nutrients · doi:10.3390/nu14194116 · Cited by 107
Self-citationMicrobial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights
Parida, S., & Sharma, D. (2020) · Cells · doi:10.3390/cells9051091 · Cited by 81
Breast cancer stem cell antigens as targets for immunotherapy
Quaglino, E., Conti, L., & Cavallo, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101386 · Cited by 91
Intratumor microbiome in cancer progression: current developments, challenges and future trends
Liu, J., & Zhang, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00381-5 · Cited by 80
Pellegrini, M., Ippolito, M., Monge, T., Violi, R., Cappello, P., Ferrocino, I., Cocolin, L. S., De Francesco, A., Bo, S., & Finocchiaro, C. (2020) · Nutrition · doi:10.1016/j.nut.2020.110749 · Cited by 77
Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
Sipe, L. M., Chaib, M., Pingili, A. K., Pierre, J. F., & Makowski, L. (2020) · Immunological Reviews · doi:10.1111/imr.12856 · Cited by 78
Sampsell, K., Hao, D., & Reimer, R. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239239 · Cited by 81
Cancer-fighting potentials of algal polysaccharides as nutraceuticals
Ouyang, Y., Qiu, Y., Liu, Y., Zhu, R., Chen, Y., El-Seedi, H. R., Chen, X., & Zhao, C. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110522 · Cited by 78
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 74
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 82
Li, G., Sun, Y., Huang, Y., Lian, J., Wu, S., Luo, D., & Gong, H. (2023) · BMC Cancer · doi:10.1186/s12885-023-10844-z · Cited by 77
Simpson, J. B., Walker, M. E., Sekela, J. J., Ivey, S. M., Jariwala, P. B., Storch, C. M., Kowalewski, M. E., Graboski, A. L., Lietzan, A. D., Walton, W. G., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.04.018 · Cited by 78
The oncogenic roles of bacterial infections in development of cancer
Eyvazi, S., Vostakolaei, M. A., Dilmaghani, A., Borumandi, O., Hejazi, M. S., Kahroba, H., & Tarhriz, V. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104019 · Cited by 75
Zhao, Q., Jiang, Y., Zhao, Q., Manzi, H. P., Li, S., Liu, D., Huang, X., Long, D., Tang, Z., & Zhang, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1213010 · Cited by 78
The Gut Microbiome: A New Player in Breast Cancer Metastasis
Ingman, W. V. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1698 · Cited by 75
Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer
Bawaneh, A., Wilson, A. S., Levi, N., Howard-McNatt, M. M., Chiba, A., Soto‐Pantoja, D. R., & Cook, K. L. (2022) · Cancers · doi:10.3390/cancers14194849 · Cited by 72
Jaye, K. M., Chang, D., Li, C. G., & Bhuyan, D. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169490 · Cited by 66
tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors
Zhang, J., Lu, R., Zhang, Y., Matuszek, Ż., Zhang, W., Xia, Y., Pan, T., & Sun, J. (2020) · Cancers · doi:10.3390/cancers12030628 · Cited by 63
Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
Noci, V. L., Bernardo, G., Bianchi, F., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732192 · Cited by 63
Significance of human microbiome in breast cancer: Tale of an invisible and an invincible
Chadha, J., Nandi, D., Atri, Y., & Nag, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.010 · Cited by 63
The intratumoral microbiome: Characterization methods and functional impact
Heymann, C. J. F., Bard, J.-M., Heymann, M.-F., Heymann, D., & Bobin-Dubigeon, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.009 · Cited by 57
Wu, X., Zhang, W., Zhao, X., Zhang, L., Xu, M., Hao, Y., Xiao, J., Zhang, B., Li, J., Kraft, P. L., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02876-w · Cited by 67
Sári, Z., Mikó, E., Kovàcs, T., Boratkó, A., Ujlaki, G., Jankó, L., Kiss, B., Uray, K., & Bai, P. (2020) · Cancers · doi:10.3390/cancers12102915 · Cited by 64
Schreurs, M. P. H., van Steenwijk, P. J. D. V., Romano, A., Dieleman, S., & Werner, H. M. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132916 · Cited by 60
Role of Microbiota in Pathogenesis and Management of Viral Hepatitis
Sehgal, R., Bedi, O., & Trehanpati, N. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00341 · Cited by 53
Arnone, A. A., & Cook, K. L. (2022) · Endocrinology · doi:10.1210/endocr/bqac177 · Cited by 54
Chen, Q., Wang, B., Wang, S., Qian, X., Xiu, L., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · Nutrients · doi:10.3390/nu13061793 · Cited by 58
Guan, X., Ma, F., Sun, X., Li, C., Li, L., Liang, F., Li, S., Yi, Z., Liu, B., & Xu, B. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00902 · Cited by 57
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Rosean, C. B., Feng, T.-Y., Azar, F. N., & Rutkowski, M. R. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.005 · Cited by 55
Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease
Sharma, V., Singh, M. P., Kumar, V., Yadav, M. K., Sehrawat, N., Sharma, D. K., & Sharma, A. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.07.006 · Cited by 51
Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment
Farhat, E. K., Sher, E. K., Džidić-Krivić, A., Banjari, I., & Sher, F. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109368 · Cited by 51
Association between the microbiota and women’s cancers – Cause or consequences?
Alizadehmohajer, N., Shojaeifar, S., Nedaeinia, R., Esparvarinha, M., Mohammadi, F., Ferns, G. A., Ghayour‐Mobarhan, M., Manian, M., & Balouchi, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110203 · Cited by 53
Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
El‐Mowafy, M., Elgaml, A., El‐Mesery, M., Sultan, S., Ahmed, T. A., Gomaa, A. I., Aly, M., & Mottawea, W. (2021) · Biology · doi:10.3390/biology10010055 · Cited by 52
Microbiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 61
Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot Study
Yang, P., Wang, Z., Peng, Q., Lian, W., & Chen, D. (2021) · Evolutionary Bioinformatics · doi:10.1177/11769343211057573 · Cited by 52
The Relationship Between Microbial Community and Breast Cancer
Song, X., Wei, C., & Li, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.849022 · Cited by 47
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Papakonstantinou, A., Nuciforo, P. G., Borrell, M., Zamora, E., Pimentel, I., Saura, C., & Oliveira, M. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102470 · Cited by 51
Exploring the impact of gut microbiota and diet on breast cancer risk and progression
Teng, N. M. Y., Price, C. A., McKee, A. M., Hall, L. J., & Robinson, S. D. (2021) · International Journal of Cancer · doi:10.1002/ijc.33496 · Cited by 51
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Malla, R. R., Marni, R., Kumari, S., Chakraborty, A., & Pappu, L. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.09.002 · Cited by 46
Pons, D. G., Vilanova-Llompart, J., Bover, A. G., Alorda-Clara, M., Oliver, J., Roca, P., & Sastre‐Serra, J. (2019) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2019.1597025 · Cited by 43
Microbiota composition in bilateral healthy breast tissue and breast tumors
Klann, E. M., Williamson, J. M., Tagliamonte, M. S., Ukhanova, M., Asirvatham, J. R., Chim, H., Yaghjyan, L., & Mai, V. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01338-5 · Cited by 50
Dey, P., & Chaudhuri, S. R. (2022) · Biology · doi:10.3390/biology11050757 · Cited by 46
Microbiota and epigenetics: promising therapeutic approaches?
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15623-6 · Cited by 47
Vafa, S., Zarrati, M., Malakootinejad, M., Totmaj, A. S., Zayeri, F., Salehi, M., Sanati, V., & Haghighat, S. (2020) · The Breast · doi:10.1016/j.breast.2020.08.008 · Cited by 43
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
Lorenzo, A. D., Bolli, E., Ruiu, R., Ferrauto, G., Gregorio, E. D., Avalle, L., Savino, A., Poggio, P., Merighi, I. F., Riccardo, F., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2086752 · Cited by 48
Hadžega, D., Minárik, G., Karaba, M., Kaľavská, K., Benca, J., Čierniková, S., Sedláčková, T., Nemcova, P., Boháč, M., Pinďák, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169058 · Cited by 40
Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls
Aarnoutse, R., Hillege, L. E., Ziemons, J., de Vos‐Geelen, J., de Boer, M., Aerts, E. M. E. R., Vriens, B. E. P. J., van Riet, Y., Vincent, J., van de Wouw, A. J., et al. (2021) · Cancers · doi:10.3390/cancers13246200 · Cited by 45
Gal, J., Bailleux, C., Chardin, D., Pourcher, T., Gilhodes, J., Jing, L., Guigonis, J., Ferrero, J.-M., Milano, G. A., Mograbi, B., et al. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.05.021 · Cited by 48
Antibiotic use and the risk of breast cancer: A systematic review and dose-response meta-analysis
Simin, J., Tamimi, R. M., Engstrand, L. G., Callens, S. F. J., & Brusselaers, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105072 · Cited by 41
Dysbiosis and extraintestinal cancers
He, R., Qi, P., Shu, L.-Z., Ding, Y., Zeng, P., Wen, G., Xiong, Y., & Deng, H. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03313-x · Cited by 49
Han, B., Jiang, P., Jiang, L., Li, X., & Ye, X. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110147 · Cited by 36
Chen, F., Yang, J., Guo, Y., Su, D., Sheng, Y., & Wu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140995 · Cited by 45
Gut microbiota, an emergent target to shape the efficiency of cancer therapy
Kouidhi, S., Zidi, O., Belkhiria, Z., Raïs, H., Ayadi, A., Ayed, F. B., Mosbah, A., Cherif, A., & Gaaied, A. B. A. E. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00132 · Cited by 39
Wilkie, T., Verma, A. K., Zhao, H., Charan, M., Ahirwar, D. K., Kant, S., Pancholi, V., Mishra, S., & Ganju, R. K. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12975 · Cited by 43
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 39
Harnessing actinobacteria potential for cancer prevention and treatment
Pongen, Y. L., Thirumurugan, D., Ramasubburayan, R., & Prakash, S. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106324 · Cited by 40
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Haque, S., Raina, R., Afroze, N., Hussain, A., Alsulimani, A., Singh, V., Mishra, B. N., Kaul, S., & Kharwar, R. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.024 · Cited by 38
Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer
Hossain, F. M., Majumder, S., David, J., Bunnell, B. A., & Miele, L. (2021) · Nutrients · doi:10.3390/nu13103656 · Cited by 39
Wang, Y., Ku, W., Liu, C., Cheng, Y., Chien, C., Chang, K., & Huang, C. (2021) · Diagnostics · doi:10.3390/diagnostics11122270 · Cited by 36
Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer
Jiang, Y., & Li, Y. (2024) · Nutrients · doi:10.3390/nu16162644 · Cited by 41
Sante, G. D., Pagé, J., Jiao, X., Nawab, O., Cristofanilli, M., Skordalakes, E., & Pestell, R. G. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1615889 · Cited by 34
Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis
Zhang, X., Yu, L., Shi, J., Li, S., Yang, S., Gao, W., Yang, S., Cheng, M., Wang, H., Guo, Z., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93428-w · Cited by 35
Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
Al‐Ansari, M. M., AlMalki, R. H., Dahabiyeh, L. A., & Rahman, A. M. A. (2021) · Metabolites · doi:10.3390/metabo11110758 · Cited by 36
Burcher, K. M., Burcher, J. T., Inscore, L., Bloomer, C. H., Furdui, C. M., & Porosnicu, M. (2022) · Cancers · doi:10.3390/cancers14174116 · Cited by 37
Luo, S., Wang, Y., Kang, X., Liu, P., & Wang, G. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105809 · Cited by 38
The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
Qasem, H., & El-Sayed, W. M. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01523-9 · Cited by 34
Metadata
- Authors
- Fernández, M. F., Reina-Pérez, I., Astorga, J. M., Rodríguez-Carrillo, A., Plaza-Díaz, J., & Fontana, L.
- Affiliations
- Universidad de Granada (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Department of Radiology, School of Medicine, and Biomedical Research Center, University of Granada, 18071 Granada, Spain
- Health Research Institute of Granada (ibs.GRANADA), 18010 Granada, Spain
- Corresponding author
- Fernández, Mariana F.
- Fontana, Luis
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2018-08-14
- Volume
- 15
- Issue
- 8
- Pages
- 1747
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC6121903
- OpenAlex
- W2885273732
- Cited by
- 350
- References
- 98
- Citations by year
- 2026: 22 · 2025: 38 · 2024: 51 · 2023: 48 · 2022: 46 · 2021: 70 · 2020: 47 · 2019: 24 · 2018: 2
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejería de Salud, Junta de Andalucía (PI-0538-2017)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- breast cancer, gut microbiota, dysbiosis, estrogen metabolism, estrogenic compounds, cancer risk assessment, cancer prevention, tumor response, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Breast Neoplasms, Estrogens, Female, Humans, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.